Status:

UNKNOWN

Montage-Enhanced Sternal Closure

Lead Sponsor:

University of Calgary

Collaborating Sponsors:

Abyrx, Inc.

Conditions:

Sternal Closure

Eligibility:

All Genders

19-79 years

Phase:

PHASE2

Brief Summary

Post-operative recovery after cardiac surgery is influenced by early sternal bone stability. Traditional sternal closure of median sternotomy usually entails the use of 6-10 stainless steel wires. Aug...

Detailed Description

Patients undergoing cardiac surgery who are participating in the study will be randomized to either conventional wire cerclage or conventional wire closure plus the use of Montage bone putty. Patients...

Eligibility Criteria

Inclusion

  • undergoing non-emergent cardiac surgery ( cabg only or one valve procedure)
  • full median sternotomy approach, with or without cardiopulmonary bypass
  • English speaking
  • geographically accessible
  • written consent

Exclusion

  • Recent CPR
  • previous cardiac surgery
  • emergency surgery ( within 24 hrs of assessment)
  • chronic lung disease
  • history of bleeding disorder
  • currently taking Vitamin E supplements
  • recent antiplatelet therapy
  • excessively poor baseline health-related quality of life or physical functioning
  • previous radiotherapy to chest, or on immunosuppressive drugs or current immunosuppressive condition
  • active significant systemic infection, history of recurrent infections,
  • cognitive impairment ( confusion, dementia, Alzheimer's, current substance abuse)
  • history of malignancy within the past year
  • recent history of significant alcohol or drug abuse
  • females who are pregnant, nursing, or child bearing potential who are not practicing a highly reliable birth control method
  • postsurgical life expectancy of less than 90 days
  • moderate to severe pectus deformity
  • participation in another study

Key Trial Info

Start Date :

October 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2022

Estimated Enrollment :

65 Patients enrolled

Trial Details

Trial ID

NCT03365843

Start Date

October 1 2018

End Date

December 1 2022

Last Update

September 28 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Calgary

Calgary, Alberta, Canada, T2N 2T9